Blue Eagle Immo SA
The score of Blue Eagle Immo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -88 % Equity +2 % Total assets +48 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Blue Eagle Immo's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 38,699 € | ||||
| Net result | 34,163 € | ||||
| Equity | 376,358 € | ||||
| Cash | 142,902 € | ||||
| EBITDA | 121,081 € | ||||
| Total assets | 870,157 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Blue Eagle Immo's financial analysis
- Solvency43.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Blue Eagle Immo
Blue Eagle Immo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.676.862
- VAT number
- BE0459676862
- Peppol
- Registered · 0208:0459676862 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Dec 1996
- Registered office
- 2340 Beerse
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Blue Eagle Immo (SA) has been based in Beerse since 1996, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of 38,699 €, a net profit of 34,163 € and equity of 376,358 €. Its solvency stands at 43.3%, below the median of its sector (46.0%).
Companies similar to Blue Eagle Immo
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Research, Development AND Sales FOR Medecine Wholesale of pharmaceutical and medical goods Hasselt · balance sheet 856,599 €
- Cair Belgium Wholesale of pharmaceutical and medical goods Liège · balance sheet 900,021 €
Frequently asked questions about Blue Eagle Immo
What is the revenue of Blue Eagle Immo?
According to the 2025 annual accounts filed with the NBB, the revenue of Blue Eagle Immo amounts to 38,699 €.
What is the VAT number of Blue Eagle Immo?
In Belgium, the VAT number is the company number prefixed with BE: BE0459676862 for Blue Eagle Immo, if the company is VAT-registered. Its company number (CBE) is 0459.676.862.
Where is the registered office of Blue Eagle Immo?
According to the CBE register, the registered office of Blue Eagle Immo is in 2340 Beerse.
What is the equity of Blue Eagle Immo?
At the close of the 2025 financial year, the equity of Blue Eagle Immo amounts to 376,358 €, a solvency of 43.3% of total assets.
Who manages Blue Eagle Immo?
The register lists 3 active mandates at Blue Eagle Immo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Blue Eagle Immo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →